
Sign up to save your podcasts
Or


Dr Jesús Berdeja from the Sarah Cannon Research Institute in Nashville, Tennessee, discusses recent advances and future directions in the use of CAR T-cell therapy for the management of multiple myeloma.
CME information and select publications here.
By Research To Practice5
66 ratings
Dr Jesús Berdeja from the Sarah Cannon Research Institute in Nashville, Tennessee, discusses recent advances and future directions in the use of CAR T-cell therapy for the management of multiple myeloma.
CME information and select publications here.

66 Listeners

30 Listeners

75 Listeners

14 Listeners

17 Listeners

4 Listeners

2 Listeners

12 Listeners

0 Listeners

122 Listeners